| September 18, 2015 |
 | The first application to pursue CRISPR/Cas9 genome-editing research in viable human embryos has been submitted to the UK’s fertility regulator by a team of researchers affiliated with the Francis Crick Institute in London. “This research proposal is a troubling and provocative move,” commented Marcy Darnovsky, PhD, Executive Director of the Center for Genetics and Society. “Modifying the …more… |
No comments:
Post a Comment